Levamisole treatment reduced the LC3B mRNA and protein levels, upregulated Beclin-1 mRNA and protein levels, and increased P62 mRNA expression level in the spleen, in contrast with the infection group (p < 0.01) (Figure 5). The gene discussed is MAP1LC3B; the disease is infection.